Cargando…
The chimeric Japanese encephalitis/Dengue 2 virus protects mice from challenge by both dengue virus and JEV virulent virus
Autores principales: | Yang, Jian, Yang, Huiqiang, Li, Zhushi, Lin, Hua, Zhao, Yu, Wang, Wei, Tan, Shuai, Zeng, Xianwu, Li, Yuhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Higher Education Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5326627/ https://www.ncbi.nlm.nih.gov/pubmed/28124229 http://dx.doi.org/10.1007/s13238-016-0363-5 |
Ejemplares similares
-
Bivalent vaccine platform based on Japanese encephalitis virus (JEV) elicits neutralizing antibodies against JEV and hepatitis C virus
por: Saga, Ryohei, et al.
Publicado: (2016) -
Envelope Protein Mutations L107F and E138K Are Important for Neurovirulence Attenuation for Japanese Encephalitis Virus SA14-14-2 Strain
por: Yang, Jian, et al.
Publicado: (2017) -
Perspectives Regarding the Risk of Introduction of the Japanese Encephalitis Virus (JEV) in the United States
por: Oliveira, Ana R. S., et al.
Publicado: (2020) -
Amino Acid at Position 166 of NS2A in Japanese Encephalitis Virus (JEV) Is Associated with In Vitro Growth Characteristics of JEV
por: Tajima, Shigeru, et al.
Publicado: (2020) -
Discordant Activity of Kaempferol Towards Dengue Virus and Japanese Encephalitis Virus
por: Care, Chit, et al.
Publicado: (2020)